Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 111

Sort by

Sort Order Select

Journal Articles

Influenza vaccine coverage, effectiveness, and disease burden among pediatric sickle cell patients in Connecticut from 2021-2024: A test-negative case-control study

Precious Nchekwube, Hillary Kuzaro, Elizabeth Cohen, Cecelia Calhoun, Lakshmanan Krishnamurti, Farzana Pashankar, Nitya Bakshi, Inci Yildirim

Blood (2025) 146 (Supplement 1): 4745.

https://doi.org/10.1182/blood-2025-4745

Published: 2025

Journal Articles

Longterm survival and late effects following hematopoietic cell transplantation for sickle cell disease into a modern era: A center for international blood and marrow transplant research (CIBMTR) analysis

Elizabeth Stenger, Ruta Brazauskas, Andrew Peterson, Stephanie Bo-Subait, Minoo Battiwalla, David Buchbinder, Betty K. Hamilton, Bipin Savani, Helene Schoemans, Michelle Schoettler, Mohamed Sorror, Rachel Phelan, Shalini Shenoy, Lakshmanan Krishnamurti

Blood (2025) 146 (Supplement 1): 1051.

https://doi.org/10.1182/blood-2025-1051

Published: 2025

Journal Articles

CRISPR-Cas12a gene editing of the HBG1/2 promoters leads to sustained normalization of total hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease: Updated Results from the RUBY trial

Blood (2025) 146 (Supplement 1): 4314.

https://doi.org/10.1182/blood-2025-4314

Published: 2025

Journal Articles

Temporal external validation of an individuals machine learning clinical decision support prediction tool for hematopoietic cell transplantation for sickle cell disease

Rajagopal Chandrashekhar, Shivapriya Somasundaram, Michael Kane, Lakshmanan Krishnamurti

Blood (2025) 146 (Supplement 1): 4372.

https://doi.org/10.1182/blood-2025-4372

Published: 2025

Journal Articles

Reduced intensity haploidentical bone marrow transplantation in children with severe sickle cell disease (SCD): BMT CTN 1507

Blood (2025) 146 (Supplement 1): 164.

https://doi.org/10.1182/blood-2025-164

Published: 2025

Journal Articles

Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations

Blood (2025) 146 (Supplement 1): 8.

https://doi.org/10.1182/blood-2025-8

Published: 2025

Journal Articles

Innate immune dysregulation in monocytes in sickle cell disease

Sarah Hinderstein, Gemma Vidal-Pedrola, Subhasis Mohanty, Irene Matos, Fanny Alarcon, Judith Carbonella, Cecelia Calhoun, Lakshmanan Krishnamurti, Albert Shaw, Inci Yildirim

Blood (2025) 146 (Supplement 1): 1155.

https://doi.org/10.1182/blood-2025-1155

Published: 2025

Journal Articles

Large Scale Community-Based Sickle Cell Surveillance in an Aboriginal Population from Western India

Uday Yanamandra, Harikrishnan Premdeep, Akash Dixit, J Muthukrishnan, Narendra Kotwal, Velu Nair, Lakshmanan Krishnamurti

Blood (2024) 144 (Supplement 1): 3681.

https://doi.org/10.1182/blood-2024-210946

Published: 2024

Journal Articles

Predictors of Graft Failure Beyond 24 Months Following Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Priyanshi Maurya, Jingchen Liang, Daniel Prior, Sai Prasad Ramachandran, Yanhong Deng, Lakshmanan Krishnamurti

Blood (2024) 144 (Supplement 1): 1063.

https://doi.org/10.1182/blood-2024-211409

Published: 2024

Journal Articles

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Karthik Chetlapalli, Ayesha Butt, Satoko Ito, Daniel Wang, Cecelia Calhoun, Lakshmanan Krishnamurti, Ankur Pandya, George Goshua

Blood (2024) 144 (Supplement 1): 601.

https://doi.org/10.1182/blood-2024-203234

Published: 2024

Journal Articles

Sickle Pain-Related Impact (SPiRIt): A Prospective Study of Impact of Chronic Pain in Sickle Cell Disease

Ashna Jagtiani, Cynthia Sinha, Ashleigh Hawk, Scott Gillespie, Mona Mirbeyk, Fuad El Rassi, Wally R Smith, Lakshmanan Krishnamurti, Soumitri Sil, Nitya Bakshi

Blood (2024) 144 (Supplement 1): 3899.

https://doi.org/10.1182/blood-2024-210575

Published: 2024

Journal Articles

Prediction of Event Free Survival in Hematopoietic Cell Transplantation: A Machine Learning Clustering and Proximity Analysis

Rajagopalan Subramaniam, Michael Kane, Lakshmanan Krishnamurti

Blood (2024) 144 (Supplement 1): 5007.

https://doi.org/10.1182/blood-2024-212195

Published: 2024

Journal Articles

Genome-Wide Association Study of Chronic Pain in Sickle Cell Disease

Anna Sowa, Yue Hu, Mark T. Gladwin, Victor R. Gordeuk, Seyed Mehdi Nouraie, Yingze Zhang, Farzana D. Pashankar, Lakshmanan Krishnamurti, Jeffrey Gruen

Blood (2024) 144 (Supplement 1): 5298.

https://doi.org/10.1182/blood-2024-208093

Published: 2024

Journal Articles

Genome-Wide Association Study Identifies Novel Genetic Variants Associated with Avascular Necrosis in Sickle Cell Disease

Anna Sowa, Yue Hu, Mark T. Gladwin, Victor R. Gordeuk, Seyed Mehdi Nouraie, Yingze Zhang, Farzana D. Pashankar, Lakshmanan Krishnamurti, Jeffrey Gruen

Blood (2024) 144 (Supplement 1): 5297.

https://doi.org/10.1182/blood-2024-207552

Published: 2024

Journal Articles

Age at Hematopoietic Cell Transplantation Is a Risk Factor for Transplant Associated Thrombotic Microangiopathy in Patients with Sickle Cell Disease

Sai Prasad Ramachandran, Jingchen Liang, Daniel Prior, Priyanshi Maurya, Yanhong Deng, Lakshmanan Krishnamurti

Blood (2024) 144 (Supplement 1): 2304.

https://doi.org/10.1182/blood-2024-212065

Published: 2024

Journal Articles

Pre-Transplant Liver Fibrosis Predicts Poor Overall Survival Following Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Priyanshi Maurya, Jingchen Liang, Daniel Prior, Sai Prasad Ramachandran, Yanhong Deng, Lakshmanan Krishnamurti

Blood (2024) 144 (Supplement 1): 2302.

https://doi.org/10.1182/blood-2024-211601

Published: 2024

Journal Articles

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Blood (2023) 142 (Supplement 2): LBA-4.

https://doi.org/10.1182/blood-2023-192022

Published: 2023

Journal Articles

Comparison of Outcomes of Hematopoietic Cell Transplantation (HCT) for Asymptomatic Patients with Sickle Cell Disease (SCD) and That of Propensity Matched Symptomatic Patients Undergoing HCT

Deeksha Katoch, Vineetha Nallagatla, Lakshmanan Krishnamurti

Blood (2023) 142 (Supplement 1): 3873.

https://doi.org/10.1182/blood-2023-190977

Published: 2023

Journal Articles

Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost-Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States

George Goshua, Satoko Ito, Karthik Chetlapalli, Kunal C Potnis, Cecelia Calhoun, Lakshmanan Krishnamurti, Harlan M. Krumholz, Ankur Pandya

Blood (2023) 142 (Supplement 1): 490.

https://doi.org/10.1182/blood-2023-191072

Published: 2023

Journal Articles

Standardized Clinical Pathways Improve Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department

Jodi Forward, Donna-Ann Thomas, Shannon O'Malley, Adam Berkwitt, Cecelia Calhoun, Lakshmanan Krishnamurti, Farzana D. Pashankar

Blood (2023) 142 (Supplement 1): 2315.

https://doi.org/10.1182/blood-2023-181285

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Influenza vaccine coverage, effectiveness, and disease burden among pediatric sickle cell patients in Connecticut from 2021-2024: A test-negative case-control study

Longterm survival and late effects following hematopoietic cell transplantation for sickle cell disease into a modern era: A center for international blood and marrow transplant research (CIBMTR) analysis

CRISPR-Cas12a gene editing of the HBG1/2 promoters leads to sustained normalization of total hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease: Updated Results from the RUBY trial

Temporal external validation of an individuals machine learning clinical decision support prediction tool for hematopoietic cell transplantation for sickle cell disease

Reduced intensity haploidentical bone marrow transplantation in children with severe sickle cell disease (SCD): BMT CTN 1507

Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations

Innate immune dysregulation in monocytes in sickle cell disease

Large Scale Community-Based Sickle Cell Surveillance in an Aboriginal Population from Western India

Predictors of Graft Failure Beyond 24 Months Following Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Sickle Pain-Related Impact (SPiRIt): A Prospective Study of Impact of Chronic Pain in Sickle Cell Disease

Prediction of Event Free Survival in Hematopoietic Cell Transplantation: A Machine Learning Clustering and Proximity Analysis

Genome-Wide Association Study of Chronic Pain in Sickle Cell Disease

Genome-Wide Association Study Identifies Novel Genetic Variants Associated with Avascular Necrosis in Sickle Cell Disease

Age at Hematopoietic Cell Transplantation Is a Risk Factor for Transplant Associated Thrombotic Microangiopathy in Patients with Sickle Cell Disease

Pre-Transplant Liver Fibrosis Predicts Poor Overall Survival Following Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Comparison of Outcomes of Hematopoietic Cell Transplantation (HCT) for Asymptomatic Patients with Sickle Cell Disease (SCD) and That of Propensity Matched Symptomatic Patients Undergoing HCT

Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost-Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States

Standardized Clinical Pathways Improve Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only